|
US6960579B1
(en)
|
1998-05-19 |
2005-11-01 |
Alcon Manufacturing, Ltd. |
Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
|
|
GB9902047D0
(en)
*
|
1999-01-29 |
1999-03-17 |
Cerebrus Ltd |
Chemical compounds XI
|
|
US6465467B1
(en)
|
1999-05-21 |
2002-10-15 |
Biovitrum Ab |
Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
|
|
GB9918965D0
(en)
|
1999-08-11 |
1999-10-13 |
Cerebrus Ltd |
Chemical compounds xxi
|
|
WO2001040183A1
(en)
*
|
1999-12-03 |
2001-06-07 |
Alcon Universal Ltd. |
1-aminoalkyl-1h-indoles for treating glaucoma
|
|
US6806285B1
(en)
|
2000-03-17 |
2004-10-19 |
Alcon, Inc. |
5-Hydroxyl indole derivatives for treating glaucoma
|
|
EP1263434A1
(en)
*
|
2000-03-17 |
2002-12-11 |
Alcon, Inc |
Compounds with 5-ht 2 and 5-ht 1a agonist activity for treating glaucoma
|
|
US7012090B1
(en)
|
2000-03-17 |
2006-03-14 |
Alcon, Inc. |
Pyranoindoles for treating glaucoma
|
|
GB0019950D0
(en)
*
|
2000-08-12 |
2000-09-27 |
Smithkline Beecham Plc |
Compounds
|
|
JP4204315B2
(ja)
|
2000-11-20 |
2009-01-07 |
ビオヴィトルム・アクチボラゲット（プブリクト） |
セロトニン５−ｈｔ２レセプターのアンタゴニストとしてのピペラジニルピラジン化合物
|
|
SE0004245D0
(sv)
|
2000-11-20 |
2000-11-20 |
Pharmacia Ab |
Novel compounds and their use
|
|
CA2432122A1
(en)
|
2000-12-20 |
2002-08-01 |
Bristol-Myers Squibb Pharma Company |
Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
|
|
CN1512879A
(zh)
|
2001-06-01 |
2004-07-14 |
�Ƹ��� |
新的芳氨基丙烷类似物及其用于治疗青光眼的用途
|
|
WO2002098350A2
(en)
|
2001-06-01 |
2002-12-12 |
Alcon, Inc. |
Pyranoindazoles and their use for the treatment of glaucoma
|
|
EP1392658A4
(en)
|
2001-06-01 |
2004-10-13 |
Alcon Inc |
NOVEL FUSED INDAZOLES AND INDOLES AND THEIR USE IN THE TREATMENT OF GLAUCOMES
|
|
US6884816B2
(en)
|
2001-08-31 |
2005-04-26 |
Alcon, Inc. |
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
|
|
TW593302B
(en)
|
2001-12-20 |
2004-06-21 |
Alcon Inc |
Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
|
|
MXPA04012711A
(es)
|
2002-06-19 |
2005-03-23 |
Biovitrum Ab |
Nuevos compuestos, su uso y preparacion.
|
|
KR20050033654A
(ko)
*
|
2002-08-30 |
2005-04-12 |
알콘, 인코퍼레이티드 |
치환된 5-크로만-5-일-에틸아민 화합물 및 녹내장의 치료용그의 용도
|
|
HRP20050396A2
(en)
|
2002-11-07 |
2005-06-30 |
Akzo Nobel N.V. |
Indoles useful in the treatment of androgen-receptor related diseases
|
|
EP1581209A4
(en)
|
2002-12-13 |
2009-03-11 |
Alcon Inc |
NEW BENZOPYRAN ANALOGUE AND ITS USE FOR THE TREATMENT OF GLAUKOM
|
|
CL2004000826A1
(es)
|
2003-04-25 |
2005-03-04 |
Pfizer |
Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
|
|
GB0314967D0
(en)
*
|
2003-06-26 |
2003-07-30 |
Hoffmann La Roche |
Piperazine derivatives
|
|
WO2005053688A1
(en)
|
2003-11-26 |
2005-06-16 |
Alcon, Inc. |
Substituted furo[2,3-g] indazoles for the treatment of glaucoma
|
|
US7338972B1
(en)
|
2003-12-15 |
2008-03-04 |
Alcon, Inc. |
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
|
|
WO2005058911A2
(en)
|
2003-12-15 |
2005-06-30 |
Alcon, Inc. |
Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
|
|
US7129257B1
(en)
|
2003-12-15 |
2006-10-31 |
Alcon, Inc. |
Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
|
|
TW200602317A
(en)
|
2004-04-23 |
2006-01-16 |
Akzo Nobel Nv |
Novel androgens
|
|
EP2248524A3
(en)
|
2004-08-25 |
2011-03-09 |
Takeda Pharmaceutical Company Limited |
Preventives/remedies for stress urinary incontinence and method of screening the same
|
|
US7425572B2
(en)
|
2004-12-08 |
2008-09-16 |
Alcon, Inc. |
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
|
|
AP2007004144A0
(en)
*
|
2005-03-31 |
2007-08-31 |
Pfizer Prod Inc |
Cyclopentapyridine and tetrahydroquinoline derivatives
|
|
CN101151249B
(zh)
*
|
2005-03-31 |
2011-04-06 |
辉瑞产品公司 |
环戊吡啶及四氢喹啉衍生物
|
|
WO2007132841A1
(ja)
|
2006-05-16 |
2007-11-22 |
Takeda Pharmaceutical Company Limited |
縮合複素環化合物およびその用途
|
|
CA2657640A1
(en)
*
|
2006-07-14 |
2008-01-24 |
Pfizer Products Inc. |
Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine
|
|
GB0715047D0
(en)
*
|
2007-08-02 |
2007-09-12 |
Glaxo Group Ltd |
Novel Compounds
|
|
JP5520051B2
(ja)
|
2007-11-15 |
2014-06-11 |
武田薬品工業株式会社 |
縮合ピリジン誘導体およびその用途
|
|
KR101062376B1
(ko)
|
2008-04-10 |
2011-09-06 |
한국화학연구원 |
신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
|
|
WO2011071136A1
(ja)
|
2009-12-11 |
2011-06-16 |
アステラス製薬株式会社 |
線維筋痛症治療剤
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
WO2017125932A1
(en)
*
|
2016-01-21 |
2017-07-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Indoline derivatives, compositions comprising them and uses thereof
|
|
JP7168456B2
(ja)
*
|
2016-07-08 |
2022-11-09 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティ オブ アリゾナ |
インドリン誘導体およびそれらを使用するならびに生産する方法
|
|
WO2018064465A1
(en)
|
2016-09-29 |
2018-04-05 |
The Regents Of The University Of California |
Compounds for increasing neural plasticity
|
|
WO2019131902A1
(ja)
|
2017-12-27 |
2019-07-04 |
武田薬品工業株式会社 |
腹圧性尿失禁および便失禁の治療薬
|
|
BR112021016620A2
(pt)
|
2019-02-27 |
2021-11-03 |
Univ California |
Azepino-indóis e outros heterociclos para o tratamento de distúrbios cerebrais
|
|
JP7636796B2
(ja)
|
2019-02-27 |
2025-02-27 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
脳障害を治療するためのｎ－置換インドール及び他の複素環化合物
|
|
CA3182182A1
(en)
*
|
2020-06-10 |
2021-12-16 |
Florence Wagner |
Isotryptamine psychoplastogens and uses thereof
|
|
CA3239565A1
(en)
|
2021-12-15 |
2023-06-22 |
Delix Therapeutics, Inc. |
Phenoxy and benzyloxy substituted psychoplastogens and uses thereof
|
|
IL316416A
(en)
*
|
2022-04-19 |
2024-12-01 |
Mindset Pharma Inc |
Indoline derivatives as estrogenic agents for the treatment of disorders
|